RecruitingNot applicableNCT05037461

Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients

Studying Neuroendocrine tumor of pancreas

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
J.M. de Laat
Intervention
High-dose-high precision MR-guided radiotherapy(radiation)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2026

Study locations (1)

Collaborators

Radboud University Medical Center · Erasmus Medical Center · Maastricht University Medical Center · Leiden University Medical Center · University Medical Center Groningen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05037461 on ClinicalTrials.gov

Other trials for Neuroendocrine tumor of pancreas

Additional recruiting or active studies for the same condition.

See all trials for Neuroendocrine tumor of pancreas →

← Back to all trials